The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells-Reference-Cited by-同舟云学术

The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells

Published:2018-11 Issue:9 Volume:41 Page:385-398
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Merz Christian,Sykora Jaromir,Marschall Viola,Richards David M.,Heinonen Karl,Redondo Müller Mauricio,Thiemann Meinolf,Schnyder Tim,Fricke Harald,Hill Oliver,Gieffers Christian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference51 articles.

1. T cell-B cell thymic cross-talk: maintenance and function of thymic B cells requires cognate CD40-CD40 ligand interaction;Fujihara;J Immunol,2014

2. The Fas/CD95 receptor regulates the death of autoreactive B cells and the selection of antigen-specific B cells;Koncz;Front Immunol,2012

3. Vaccination produces CD4 T cells with a novel CD154-CD40-dependent cytolytic mechanism;Coler;J Immunol,2015

4. CD40-activated B cells can efficiently prime antigen-specific naive CD8+ T cells to generate effector but not memory T cells;Mathieu;PLoS One,2012

5. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation;van Zelm;J Allergy Clin Immunol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble CD40 Ligand as a Promising Biomarker in Cancer Diagnosis;Cells;2024-07-28

2. Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism;Bioengineered;2024-01-12

3. Harnessing the potential of CD40 agonism in cancer therapy;Cytokine & Growth Factor Reviews;2023-12

4. Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy;Pharmaceutical Fronts;2023-12

5. The benefits of clustering in TNF receptor superfamily signaling;Frontiers in Immunology;2023-08-17